Evidence map›Paper›PMID 40717462›Full record

ArticleJournal of Parkinson's disease2025

Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease.

Daigo Tamakoshi, Keita Hiraga, Taiki Fukushima, Takashi Uematsu, Takashi Tsuboi, Maki Sato, Makoto Hattori, Yuki Satake, Atsushi Hashizume, Masayuki Yamamoto and 3 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daigo TamakoshiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0009-0003-0877-7738
Keita HiragaDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-0134-2956
Taiki FukushimaDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-3844-3099
Takashi UematsuDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0009-0006-5752-3875
Takashi TsuboiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0001-5042-3181
Maki SatoDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0009-0002-6655-9483
Makoto HattoriDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yuki SatakeDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0009-0003-9919-4297
Atsushi HashizumeDepartment of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-3098-7390
Masayuki YamamotoKumiai Kosei Hospital, Takayama, Gifu, Japan.
Hideaki ShimizuMedical Examination Center, Daido Clinic, Nagoya, Japan.ORCID 0000-0003-2975-2874
Masakazu WakaiChutoen General Medical Center, Kakegawa, Shizuoka, Japan.ORCID 0009-0007-4802-5759
Masahisa KatsunoDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0001-9453-9311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundProdromes of Parkinson's disease (PD) include both motor and non-motor symptoms. Although questionnaires have been established for non-motor symptoms, no quantitative self-assessment tool has been developed to assess subtle motor symptoms during the prodromal stage.ObjectiveTo develop a self-administered questionnaire to assess subtle motor symptoms during the prodromal stage.MethodsWe created the Screening Questionnaire for Subtle Parkinsonism (SQSP). The SQSP and questionnaires on non-motor symptoms were collected from health checkup examinees. Individuals with ≥ 2 non-motor symptoms, including autonomic dysfunction, hyposmia, and REM sleep behavior disorder, were classified as high-risk, while those without these symptoms were low-risk. We also conducted comprehensive evaluations, including neurological examinations and imaging tests, on 30 patients with PD, 71 high-risk, and 24 low-risk subjects.ResultsAmong 1183 health checkup examinees, high-risk subjects had higher SQSP scores than low-risk (9 [4-15] vs. 3 [1-6]). Patients with PD had the highest SQSP scores, followed by high-risk subjects and then low-risk. SQSP scores correlated with MDS-UPDRS II and III scores and specific binding ratios of DaT-SPECT. High-risk subjects with abnormal DaT-SPECT had higher SQSP scores than those with normal imaging (9 [7-19] vs. 5.5 [2-10]). Although 26 of the 71 high-risk and 23 of the 24 low-risk subjects scored zero on the MDS-UPDRS II, most high-risk and half low-risk subjects had SQSP scores above zero.ConclusionsThe SQSP was deemed effective for assessing subtle motor symptoms during the prodromal stage of PD and identifying prodromal PD cases within the general population.

Indexed as

Autonomic Nervous System DiseasesOlfaction DisordersParkinson DiseaseProdromal SymptomsREM Sleep Behavior DisorderAgedFemaleHumansMaleMiddle AgedSurveys and QuestionnairesTomography, Emission-Computed, Single-PhotonisotopesParkinson's diseaseprodromal symptomssurveys and questionnaires

Identifiers

PMID40717462
PMCPMC13347511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.